28 Jan - 31 Jan '17

7th EPITA Meeting & IPITA/EPITA Joint Workshop

 
The EPITA Board is happy to announce the 7th EPITA Winter Symposium & 36th AIDPIT Workshop that will take place in Innsbruck from the 29th to the 31st of

7th EPITA Meeting & IPITA/EPITA Joint Workshop

Programme Information:

============= #7EPITA PRELIMINARY PROGRAMME=========


Sunday 29th January, 2017


17:30 – 19:00 Opening Session


Chairs: Eelco de Koning, The Netherlands; Johann Pratschke, Germany


17:30 – 17:40 Welcome


Chair: Johann Pratschke, Germany


17:40 – 18:20 Pathology after pancreas - islets tx


Cinthia Beskow Drachenberg, United States


18:20 – 19:00 Genome editing


Angelo Lombardo,Italy


 


Monday 30th January, 2017


08:30 – 10:40 Session 1: Pancreas


Chairs: Steven White, United Kingdom; Peter Stock, United States


08:30 – 08:50 Normothermic perfusion for pancreas and islets tx  


Christopher Watson, United Kingdom


08:50 – 09:10 Bariatric surgery in potential tx recipients  


François Pattou, France


09:10 – 09:30 Humoral rejection after pancreas-islets tx  


Susan Fuggle, United Kingdom


09:30 – 10:40 Oral Presentations (Pancreas) 


OP1 - THE ROLE OF PANCREAS TRANSPLANT EXOCRINE SECRETIONS IN URINARY TRACT INFECTION Matthew Byrne


OP2 - PANCREATIC B-CELLS CAN RECOVER THEIR IDENTITY AFTER A MODIFIED BYPASS SURGERY Zubiaga Lorea


OP3 - AN EX-VIVO NORMOTHERMIC PORCINE PANCREAS PHYSIOLOGICAL MODEL - IMPLICATIONS FOR PANCREAS AND ISLET TRANSPLANTATION Rohan Kumar


OP4 - LONGTERM RESULTS FOLLOWING ALEMTUZUMAB VERSUS ATG INDUCTION THERAPY IN COMBINED KIDNEY-PANCREAS TRANSPLANTATION: A SINGLE CENTER REPORT Claudia Bosmuller


OP5 - CMV INFECTION WITH ALEMTUZUMAB VS. BASILIXIMAB INDUCTION THERAPY FOR SIMULTANEOUS PANCREAS AND KIDNEY (SPK) TRANSPLANTATION Aditya Kanwar


Discussion


 


10:40 – 11:00 Coffee break


11:00 – 12:40 Session 2: Islets                    


Chairs:  Michael Rickels, United States; Barbara Ludwig, United Kingdom


11:00 – 11:20 What is the perfect place for islets?


Lorenzo Piemonti, Italy                         


11:20 – 11:40 Biomarkers of beta-cell death


Bart Keymeulen, Belgium


11:40 – 12:40 Oral Presentations (Islets)


OP7 - IMPACT OF PRIMARY GRAFT FUNCTION ON LONG-TERM (10 YEARS) OUTCOME OF ISLET TRANSPLANTATION WITH THE EDMONTON PROTOCOL Marie-Christine Vantyghem


OP8 - ISLET ALLO-AUTOTRANSPLANTATION: ALLOGENEIC PANCREAS TRANSPLANTATION FOLLOWED BY TRANSPLANT PANCREATECTOMY AND ISLET TRANSPLANTATION Michiel Nijhoff


OP9 - SALVAGE ISLET AUTO TRANSPLANTATION AFTER RELAPARATOMY Lorenzo Piemonti


OP10 - TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION IN PROPERLY SELECTED PATIENTS WITH CHRONIC PANCREATITIS IMPROVES QUALITY OF LIFE ALLOWING FOR THE RESOLUTION OF THE INTRACTABLE PAIN WITH GOOD GLUCOSE CONTROL Justina Gołębiewska


OP11 - USE OF THE GLUCOSE-DEPENDENT INSULIN SECRETION RATE (GDISR) AS A NOVEL PREDICTOR OF ISLET GRAFT FUNCTION Ioannis Spiliotis


Discussion


 


13:00 – 14:10 Lunch Symposium                                    


Chair: Lorenzo Piemonti, Italy


13:00 – 13:20 Rejection and inflammation                   


Decio Eizirik, Belgium          


13:20 - 13:40 Treatment of inflammatory changes after solid organ tx              


Johann Pratschke, Ggermany


13:40 – 14:00 Beta-cell preservation                               


Emanuele Bosi, Italy


14:00 – 14:10 Concluding remarks


14:10 – 14:30 Coffee break


14:30 – 16:00 Session 3: Islets                       


Chairs: Frantisek Saudek, Czech Republic;Jochen Seissler


14:30 – 14:50 Impact of beta-cell replacement on diabetes complications           


Piero Marchetti, Italy


14:50 – 16:00 Oral Presentations (Islets)


OP12 - CREATION OF THE ARTIFICIAL CAVITY FOR SUBSEQUENT TRANSPLANTATION OF PANCREATIC ISLETS USING PLCL SCAFFOLD Jan Kritz


OP13 - INFLUENCE OF PANCREAS DONOR CHARACTERISTICS ON ISLET ISOLATION YIELD Mikael Chetboun


OP14 - REGULATED EXPRESSION OF NLRP3 INFLAMMASOME IN HUMAN ISLETS Vanessa Lavallard


OP15 - CO-CULTURE OF HUMAN ISLETS WITH EXTRACELLULAR MATRIX PROTEINS CONFERS BENEFITS ON ISLET SURVIVAL AND ISLET FUNCTION Samuel Acreman


OP16 - SYNDECAN-4 EXPRESSION IN PANCREATIC BETA CELLS Estelle Brioudes


OP17 - INTRA-OMENTAL GRAFT WITH A PLASMA HYDROGEL CARRIER: A PROMISING ALTERNATIVE FOR ISLETS TRANSPLANTATION Anais Schaschkow


Discussion


 


16:00 – 16:30 Coffee break


16:30 – 18:30 Session 4: Pro/Con: Stem Cells VS Xenotransplantation     


Chairs: Helmut Arbogast, Germany; Eelco de Koning, The Netherlands


16:30 – 16:50 Xeno  


Jochen Seissler


16:50 – 17:10 Stem cells  


Jon Odorico, United States


17:10 – 17:30 Q&A


17:30 – 18:30 Oral Presentations (Controversy)


OP18 - HOW TO OVERCOME HUMAN ISLETS DEMAND FOR RESEARCH: PRODUCTION FROM INDUCED PLURIPOTENT STEM CELLS (IPS DF19.9) Alix Vaissié


OP19 - BIOENGINEERING VASCULARIZED ISLET ORGANS FOR THE TREATMENT OF TYPE 1 DIABETES Antonio Citro


OP20 - LIGHT/TNFSF14 AND GLUCOTOXICITY INDUCE AN ADVERSE EFFECT ON HUMAN ISLETS THROUGH ELEVATION OF ISLET DYSFUNCTION AND APOPTOSIS Shadab Abadpour


OP21 - PRISM: A FAST, COMPACT, IN-LINE, HIGH YIELD, HUMAN PANCREATIC ISLET ISOLATION METHOD Jason Doppenberg


OP22 - RAPID REMOVAL OF ALL IGG AND ALL ANTI-HLA ANTIBODIES IN IMMUNIZED PATIENTS. - TWO DOSE FINDING STUDIES OF THE IGG DEGRADING ENZYME IDES Gunnar Tufveson


OP23 - TLR4 CONTRIBUTES TO THE DEVELOPMENT AND PARTICIPATES IN THE MAINTENANCE OF AUTOIMMUNE DIABETES Mohamed Alibashe Ahmed


Discussion


 


Tuesday 31st  January, 2017


09:00 – 12:20Session 5: Young Investigator Workshops


09:00 – 10:00 Pancreas and Islets Joint  


Chair: Robert Langer, Hungary


10:00 – 10:10 Break


10:10 – 12:20 Pancreas discussion tables topics:


TABLE 1: clinician commenting consequences of hepatologists’ findings with Cinthia Beskow Drachenberg


TABLE 2: thrombosis with Steven White


TABLE 3: complicated recipient


 


10:10 – 12:20 Islets discussion tables topics:


TABLE 1: “fast track” islets isolation with Marten Engelse


TABLE 2: personalized islet isolation (DCD vs. Extended donors) with Sarah Cross and Julie Kerr-Conte


TABLE 3: quality assessment after islet isolation with Barbara Ludwig


TABLE 4: collagenase with Balamurugan Appakalai


 


12:20 – 13:30 Lunch break and poster viewing


13:30 – 14:40 Novonordisk Technology Session


Chair: Roger Lehmann, Zurich, Switzerland


13:30 – 13:50 Metabolic control after pancreas/islet tx


Michael Rickels, United States


13:50 – 14:20 Symptomatic treatments or saving lives?    


Roger Lehmann, Switzerland


14:20 – 14:40 Q&A


14:40 – 15:40 Session 6: Oral Presentations (Islets)


OP24 - INFECTION RISKS AFTER PANCREATECTOMY AND AUTOLOGOUS ISLET CELL TRANSPLANTS AFTER PREVIOUS PANCREATICOJEJUNOSTOMY AND COMPLEX PANCREATIC TRAUMA Jennifer Logue


OP25 - COMPARATIVE EVALUATION OF SIMPLE INDICES USING A SINGLE FASTING BLOOD SAMPLE TO ESTIMATE BETA CELL FUNCTION AFTER ISLET TRANSPLANTATION Justyna Gołębiewska


OP26 - GONADIC AND BONE ASSESSMENT AFTER DIABETES CELL THERAPY WITH EDMONTON PROTOCOL IN WOMEN Marie-Christine Vantyghem


OP27 - EVOLUTION OF GONADAL FUNCTION AND T-SCORE AFTER CELL THERAPY FOR TYPE 1 DIABETES UNDER IMMUNOSUPPRESSION INVOLVING SIROLIMUS-TACROLIMUS Marie-Christine Vantyghem


OP28 - RECURRENCE OF SEVERE HYPOGLYCAEMIA FOLLOWING PANCREATIC ISLET TRANSPLANTATION Anneliese Flatt


Discussion


 


15:40 – 16:00 Coffee break


16:00 – 18:00 Session 7: Presidential Debate


Chair: Johann Pratschke


16:00 – 16:40 Outcomes of the EPITA+IPITA Joint Workshop (EPITA)


Michael Rickels, United States and Peter Stock, united States


16:40 – 17:40 How can we build a closer cooperation?  


Panelists: Michael Rickels, Peter Stock. Thierry Berney, Lorenzo Piemonti, Roger Lehmann, Eelco de Koning, Steve White


17:40 – 18:00 Poster Awards ceremony


18:00 – 18:15 Concluding remarks